Brief: Amphastar Pharmaceuticals Inc On March 8 Co And Nanjing Hanxin Pharmaceutical Technology Entered Amendment To Contract Research Agreement
10/03/2023 21:36
March 10 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O :
* AMPHASTAR PHARMACEUTICALS INC: ON MARCH 8 CO AND NANJING
HANXIN
PHARMACEUTICAL TECHNOLOGY ENTERED AMENDMENT TO CONTRACT RESEARCH
AGREEMENT
* AMPHASTAR PHARMACEUTICALS - UNDER AMENDMENT, HANXIN TO
PERFORM
SCALE-UP MANUFACTURING PROCESS DEVELOPMENT USING RECOMBINANT
HUMAN INSULIN RCBS FOR CO
Further company coverage: AMPH.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing